EUVIMEDEUVIMED entdecken
Crossref

High-throughput cell viability assessment using a luminescent ATP detection assay

Dana Alawieh, Marion Leduc, Sebastien Nakhla, Aline Renneville, Oliver Kepp

Methods in Cell Biology · 2026

DOI: 10.1016/bs.mcb.2025.03.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Cell Biology, 2026. Verfasst von Dana Alawieh und 4 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1287, Gustave Roussy, Paris-Saclay University, Villejuif, France. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Adenosine Triphosphate, Luminescent Measurements. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Association Laurette Fugain, Institut National Du Cancer, Ministère de l'Enseignement supérieur et de la Recherche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic myelomonocytic leukemia (CMML) is an aggressive hematologic malignancy for which no approved targeted therapies are available. Standard therapies as of now lack the ability to eradicate leukemic clones nor can they modify disease outcome. To address this therapeutic gap, we conducted a high-throughput chemical drug screen using a robotized platform on four genetically engineered hematopoietic murine cell lines that model recurrent CMML mutations. Our approach aimed to identify genotype-dependent therapeutic vulnerabilities through a drug repurposing strategy, leveraging the rapid clinical translation potential of pre-approved compounds. Cell viability was assessed using the CellTiter-Glo® luminescent cell viability assay, a robust method widely recognized for its accuracy and efficiency in measuring cell proliferation and cytotoxicity. The luminescent output, directly proportional to viable cell numbers, allows for high-throughput screening. The protocol detailed in this article enables the testing of a large number of compounds at multiple doses, with a 48-hour readout. This method provides a reliable, time-efficient, and flexible approach that can be adapted for different cell types and research contexts beyond oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Screening AssaysAdenosine TriphosphateLuminescent MeasurementsAnimalsCell SurvivalMiceCell Line, TumorCell Proliferation

Stichwörter der Autor:innen

ATP detection luminescent assayDrug repurposingHigh-throughput drug screeningRobotized platformSuspension cell lines

Substanzen

Adenosine Triphosphate

Autor:innen und Institutionen

  • INSERM U1287, Gustave Roussy, Paris-Saclay University, Villejuif, France.
  • Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Center, Université Paris Saclay, Villejuif, France; Centre de Recherche des Cordeliers, Inserm UMRS 1138, Sorbonne Université, Université Paris Cité, Équipe…
  • INSERM U1287, Gustave Roussy, Paris-Saclay University, Villejuif, France; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France. Electronic address: Aline.RENNEVILLE@gustaveroussy.fr.

Förderung

  • Association Laurette Fugain
  • Institut National Du Cancer
  • Ministère de l'Enseignement supérieur et de la Recherche
  • Association pour la Recherche sur le Cancer
  • Fondation ARC pour la Recherche sur le Cancer

Zitieren

APA

Alawieh, D., Leduc, M., Nakhla, S., Renneville, A., & Kepp, O. (2026). High-throughput cell viability assessment using a luminescent ATP detection assay. Methods in Cell Biology. https://doi.org/10.1016/bs.mcb.2025.03.015

Vancouver

Alawieh D, Leduc M, Nakhla S, Renneville A, Kepp O. High-throughput cell viability assessment using a luminescent ATP detection assay. Methods in Cell Biology. 2026. doi:10.1016/bs.mcb.2025.03.015

BibTeX
@article{Alawieh2026,
  author = {Alawieh, Dana and Leduc, Marion and Nakhla, Sebastien and Renneville, Aline and Kepp, Oliver},
  title = {High-throughput cell viability assessment using a luminescent ATP detection assay},
  journal = {Methods in Cell Biology},
  year = {2026},
  doi = {10.1016/bs.mcb.2025.03.015}
}
Kostenlos starten →